In a 75-year-old man with hypertension who remains uncontrolled despite taking losartan 100 mg daily and hydrochlorothiazide (HCTZ) 12.5 mg daily, what medication should be added next?

Add a Calcium Channel Blocker (Amlodipine) First

In this 75-year-old man with uncontrolled hypertension on losartan 100 mg and hydrochlorothiazide 12.5 mg, the next step is to add amlodipine 5–10 mg once daily to complete the guideline-mandated three-drug foundation before considering any fourth-line agent. 1

Why Amlodipine Must Be Added Before Anything Else

• The 2024 ESC and 2018 AHA guidelines explicitly require that resistant hypertension be treated with a three-drug foundation consisting of (1) a renin-angiotensin system blocker (losartan 100 mg—already at maximum dose), (2) a long-acting dihydropyridine calcium channel blocker (missing), and (3) a thiazide-like diuretic. 1, 2

• Your patient is currently on only two drug classes (ARB + thiazide), which does not meet the definition of optimized triple therapy. 1

• Amlodipine is a non-substitutable component of the core regimen; omitting it means the patient has not received adequate foundational therapy before escalating to fourth-line agents. 1

Specific Dosing and Titration

• Start amlodipine 5 mg once daily and reassess blood pressure after 2–4 weeks. 1

• If blood pressure remains ≥130/80 mmHg and the 5-mg dose is well tolerated, titrate to amlodipine 10 mg daily. 1

• Allow at least 4 weeks after optimizing all three agents at maximal tolerated doses before evaluating the need for a fourth-line agent. 1

Critical Diuretic Optimization: Switch to Chlorthalidone

• Before adding amlodipine, replace hydrochlorothiazide 12.5 mg with chlorthalidone 12.5–25 mg once daily. 1

• Thiazide-like diuretics (chlorthalidone or indapamide) provide markedly superior 24-hour blood pressure control compared with hydrochlorothiazide and are significantly more effective in resistant hypertension. 1

• Inadequate diuretic therapy is the most common reason for treatment failure in resistant hypertension; continuing hydrochlorothiazide is a critical pitfall to avoid. 1

• The optimized regimen should be: losartan 100 mg + amlodipine 5–10 mg + chlorthalidone 12.5–25 mg. 1

When to Add Spironolactone (Fourth-Line Agent)

• Spironolactone is classified as a fourth-line agent and should be added only after the triple-drug foundation (ARB + CCB + thiazide-like diuretic) is optimized at maximal tolerated doses. 1

• If blood pressure remains ≥130/80 mmHg after 4–8 weeks on losartan 100 mg + amlodipine 10 mg + chlorthalidone 25 mg, add spironolactone 25 mg once daily provided: 1

  • Serum potassium is <4.5 mmol/L (some guidelines accept ≤5.0 mmol/L), and
  • Estimated glomerular filtration rate (eGFR) is ≥45 mL/min/1.73 m² (≥30 mL/min/1.73 m² is the absolute minimum). 1

• In the PATHWAY-2 randomized controlled trial, spironolactone reduced office systolic blood pressure by approximately 13–20 mmHg, making it the most effective fourth-line agent. 1

• Monitor serum potassium and creatinine at 5–7 days, then every 3–6 months after starting spironolactone; hyperkalemia is the primary safety concern, especially when combined with an ARB. 1

Blood Pressure Target

• Aim for <130/80 mmHg in this 75-year-old patient. 1

• When tolerated, a more intensive systolic target of 120–129 mmHg is recommended. 1

Confirm True Resistant Hypertension Before Escalating

• Verify medication adherence through direct questioning, pill counts, or pharmacy records; non-adherence accounts for approximately 50% of apparent resistance. 1

• Perform 24-hour ambulatory or home blood pressure monitoring to exclude white-coat hypertension, which represents roughly 50% of apparent resistant cases. 1

• Ensure proper blood pressure measurement technique using appropriate cuff size and correct arm positioning to avoid falsely elevated readings. 1

Common Pitfalls to Avoid

• Do not add spironolactone before establishing the proper three-drug foundation (ARB + CCB + thiazide-like diuretic). 1

• Do not continue hydrochlorothiazide; switching to chlorthalidone or indapamide is the most critical optimization step and yields superior blood pressure control. 1

• Do not combine an ACE inhibitor with the existing ARB (losartan); dual RAS blockade increases adverse events such as hyperkalemia and renal dysfunction without additional cardiovascular benefit. 1